Medifast (MED)

NYSE Market Closed

Medifast, Inc. is a health and wellness company best known for OPTAVIA, its coach-supported weight management and lifestyle platform. The company’s approach combines structured nutrition, community-based support, personal coaching, and habit formation to help customers pursue weight loss and long-term behavior change. Rather than operating solely as a diet product company, Medifast positions OPTAVIA as a broader lifestyle system built around daily routines, accountability, and education.

The company offers meal replacements and other nutrition products designed to simplify calorie and portion management, while independent coaches provide guidance and encouragement throughout the customer journey. This coaching model is central to Medifast’s business, as it supports customer acquisition, engagement, and retention through personal relationships and peer communities. The company’s messaging emphasizes sustainable lifestyle transformation and making healthier habits part of everyday life.

Medifast operates in a competitive weight management market that includes commercial diet programs, consumer packaged nutrition products, fitness and wellness platforms, medical weight-loss providers, and prescription obesity treatments. The rapid growth of GLP-1 medications has reshaped the industry, and Medifast has worked to incorporate access to these therapies where clinically appropriate while continuing to offer nutrition and behavior-change support.

For investors, MED is tied to trends in obesity care, consumer wellness spending, direct selling and coaching models, and demand for structured weight-loss solutions. Its performance depends on customer acquisition, coach productivity, product appeal, brand trust, regulatory compliance, and the company’s ability to adapt as medical and lifestyle approaches to weight management increasingly overlap.

12.27 USD
12.29 USD
+0.03 (+0.25%)
After-hours

Last updated

Market Cap
136.43M
P/E
P/FCF
P/S
0.39
Enterprise Value
64.9M
Sector
Industry
Address
1501 S. CLINTON STREET, BALTIMORE, MD, 21224
GlobeNewswire Inc.

The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do

21 May 2026, 21:00 PM
GlobeNewswire Inc.

Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation

16 May 2026, 03:00 AM
GlobeNewswire Inc.

Peer-Reviewed Research Is Redefining Weight Loss Program Standards

16 May 2026, 03:00 AM
GlobeNewswire Inc.

Plant-based Beverage Market is Estimated to Reach $56.73 Billion with a 11.9% CAGR By 2034 | Fact.MR Reports

21 Nov 2024, 00:00 AM
Zacks Investment Research

Medifast (MED) Q1 Earnings Miss Estimates, Revenues Fall Y/Y

01 May 2024, 02:04 AM
Zacks Investment Research

Medifast's (MED) Transformation on Track Amid Macro Headwinds

17 Apr 2024, 02:53 AM
Zacks Investment Research

Medifast (MED) Soars 5.9%: Is Further Upside Left in the Stock?

18 Mar 2024, 20:15 PM
Zacks Investment Research

Innovations Aid Medifast (MED), Lower Customer Attraction Ails

14 Mar 2024, 02:45 AM
Zacks Investment Research

Medifast (MED) Q4 Earnings Beat Estimates, Revenues Dip Y/Y

22 Feb 2024, 04:04 AM
Zacks Investment Research

Medifast (MED) Q4 Earnings Coming Up: What Should You Know?

16 Feb 2024, 23:06 PM
Zacks Investment Research

Mondelez (MDLZ) Q4 Earnings and Revenues Top Estimates

31 Jan 2024, 09:15 AM
Zacks Investment Research

Medifast's (MED) Holistic Health Solution, Innovation Bode Well

27 Dec 2023, 00:20 AM
Zacks Investment Research

Medifast (MED) Collaborates With LifeMD, Discontinues Dividend

15 Dec 2023, 03:19 AM
MarketWatch

Dow Jones closes at record high as Federal Reserve signals interest-rate pivot

14 Dec 2023, 08:23 AM
MarketWatch

LifeMD and Medifast to create weight-management program that includes GLP-1 drugs

14 Dec 2023, 02:28 AM
Zacks Investment Research

Here's How Much You'd Have If You Invested $1000 in Medifast a Decade Ago

08 Dec 2023, 00:30 AM
Zacks Investment Research

Why Is Medifast (MED) Down 1.1% Since Last Earnings Report?

07 Dec 2023, 03:30 AM
Zacks Investment Research

Medifast (MED) Poised on OPTAVIA ACTIVE Line Amid Cost Woes

25 Nov 2023, 03:03 AM
Zacks Investment Research

Medifast (MED) Q3 Earnings Top Estimates, Revenues Decline Y/Y

08 Nov 2023, 02:21 AM
Zacks Investment Research

Medifast (MED) Queues for Q3 Earnings: What Awaits the Stock?

02 Nov 2023, 22:22 PM
Market Cap
136.43M
Enterprise Value
64.9M
P/E
P/B
0.69
P/S
0.39
EV / EBITDA
-40.31
EV / Sales
0.19
EPS
-1.8
Dividend Yield
0.06%
P/FCF
P/CF
36.7
Free Cash Flow
-1.47M
ROE
-10.13%
ROA
-7.94%
Debt / Equity
0
Current Ratio
4.8
Quick Ratio
4.3
Cash
1.7
Avg Volume
197.34K
Fundamentals Snapshot Price
12.27

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 76.04M 75.1M 89.41M 105.56M 115.73M
Gross profit 51.76M 52.14M 62.16M 76.64M 84.25M
Operating income -3.3M -7.8M -4.08M -1.07M -1.26M
EBITDA 188K -4.34M -1.02M 3.56M 2.02M
Net income -2.12M -18.12M -2.26M 2.48M -772K
Basic EPS -0.19 -1.65 -0.21 0.23 -0.07
Diluted EPS -0.19 -1.65 -0.21 0.22 -0.07

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 252.05M 247.97M 268.21M 269.33M 280.01M
Total liabilities 54.37M 49.05M 53.5M 53.33M 69.05M
Total equity 197.68M 198.92M 214.71M 216.01M 210.96M
Cash & equivalents 71.53M 89.3M 99.53M 101.69M 91.72M
Current assets 202.63M 201.68M 207.84M 206.44M 213.52M
Current liabilities 42.18M 42.96M 46.71M 46.18M 60.6M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow 260K -5.28M 12.11M -3.38M 3.41M
Investing cash flow -17.13M -4.95M -14.28M 13.36M -2.05M
Financing cash flow -901K 1K 0 -2K -563K
Change in cash -17.77M -10.22M -2.17M 9.98M 789K
Kind Filing Date Link
edgar index 8-K — MEDIFAST INC View Filing
eight k text 8-K — 8-K View Filing
edgar index 3 — MEDIFAST INC View Filing
edgar index 3 — MEDIFAST INC View Filing
edgar index 4 — MEDIFAST INC View Filing
edgar index 4 — MEDIFAST INC View Filing
edgar index 4 — MEDIFAST INC View Filing
edgar index 4 — MEDIFAST INC View Filing
edgar index 4 — MEDIFAST INC View Filing
edgar index 4 — MEDIFAST INC View Filing
form 3 Form 3 — Kiai Parsa View Filing
edgar index 8-K — MEDIFAST INC View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — Xian Ming View Filing
form 4 Form 4 — Geary Elizabeth A. View Filing
form 4 Form 4 — SCHLACKMAN SCOTT View Filing
form 4 Form 4 — Thomas Andrea B View Filing
form 4 Form 4 — Kiai Parsa View Filing
form 4 Form 4 — Kiai Parsa View Filing
form 4 Form 4 — Rose Jeffrey Matthew View Filing
form 4 Form 4 — Rose Jeffrey Matthew View Filing
edgar index SCHEDULE 13G — MEDIFAST INC View Filing
edgar index SCHEDULE 13G/A — MEDIFAST INC View Filing
edgar index SCHEDULE 13G/A — MEDIFAST INC View Filing
edgar index 4 — MEDIFAST INC View Filing
form 4 Form 4 — SCHLACKMAN SCOTT View Filing
form 4 Form 4 — SCHLACKMAN SCOTT View Filing
edgar index 8-K — MEDIFAST INC View Filing
edgar index 10-Q — MEDIFAST INC View Filing
eight k text 8-K — 8-K View Filing
edgar index DEF 14A — MEDIFAST INC View Filing
edgar index DEFA14A — MEDIFAST INC View Filing
edgar index ARS — MEDIFAST INC View Filing
edgar index SCHEDULE 13G/A — MEDIFAST INC View Filing
edgar index 4 — MEDIFAST INC View Filing
edgar index 4 — MEDIFAST INC View Filing
edgar index 4 — MEDIFAST INC View Filing
edgar index 3 — MEDIFAST INC View Filing
form 3 Form 3 — Johnson Nicholas Mark View Filing
form 3 Form 3 — Johnson Nicholas Mark View Filing
form 3 Form 3 — Johnson Nicholas Mark View Filing
form 3 Form 3 — Johnson Nicholas Mark View Filing
form 3 Form 3 — Johnson Nicholas Mark View Filing
form 4 Form 4 — Chard Daniel R View Filing
form 4 Form 4 — Chard Daniel R View Filing
form 4 Form 4 — Chard Daniel R View Filing
form 4 Form 4 — Maloney James P. View Filing
form 4 Form 4 — Maloney James P. View Filing
form 4 Form 4 — Maloney James P. View Filing
form 4 Form 4 — MacKenzie Jonathan Barrett View Filing
form 4 Form 4 — MacKenzie Jonathan Barrett View Filing
edgar index SCHEDULE 13D — MEDIFAST INC View Filing
edgar index 8-K — MEDIFAST INC View Filing
eight k text 8-K — 8-K View Filing
form 4 Form 4 — Chard Daniel R View Filing
form 4 Form 4 — Chard Daniel R View Filing
form 4 Form 4 — Maloney James P. View Filing
form 4 Form 4 — MacKenzie Jonathan Barrett View Filing
form 4 Form 4 — Chard Daniel R View Filing
form 4 Form 4 — Chard Daniel R View Filing
form 4 Form 4 — Maloney James P. View Filing
form 4 Form 4 — MacKenzie Jonathan Barrett View Filing
edgar index 8-K — MEDIFAST INC View Filing
edgar index 10-K — MEDIFAST INC View Filing
eight k text 8-K — 8-K View Filing
ten k section 10-K — business View Filing
ten k section 10-K — mda View Filing
ten k section 10-K — risk_factors View Filing
edgar index SCHEDULE 13G/A — MEDIFAST INC View Filing
edgar index SCHEDULE 13G/A — MEDIFAST INC View Filing
edgar index 8-K — MEDIFAST INC View Filing
eight k text 8-K — 8-K View Filing
edgar index SCHEDULE 13G — MEDIFAST INC View Filing
edgar index SCHEDULE 13G/A — MEDIFAST INC View Filing
edgar index 8-K — MEDIFAST INC View Filing